BlackRock Inc. - DIFFUSION PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
BlackRock Inc. ownership history of DIFFUSION PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2022$411,000
-18.0%
1,642,7040.0%0.00%
Q4 2021$501,000
-39.9%
1,642,704
+0.4%
0.00%
Q3 2021$834,000
-30.2%
1,636,3340.0%0.00%
Q2 2021$1,195,000
-36.3%
1,636,334
-20.0%
0.00%
Q1 2021$1,876,000
+184.2%
2,044,449
+146.2%
0.00%
Q4 2020$660,000
-5.6%
830,4710.0%0.00%
Q3 2020$699,000
-13.7%
830,4710.0%0.00%
Q2 2020$810,000
+211.5%
830,471
+1.2%
0.00%
Q1 2020$260,000
-31.2%
820,7790.0%0.00%
Q4 2019$378,000820,7790.00%
Other shareholders
DIFFUSION PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
Yu Fan 269,544$213,0000.35%
Southland Equity Partners LLC 12,030$9,5640.01%
Sugarloaf Wealth Management, LLC 15,750$13,0000.00%
Frontier Wealth Management LLC 25,000$20,0000.00%
Renaissance Technologies 2,832,739$2,252,0000.00%
UBS Group AG 5,999$5,0000.00%
IFP Advisors, Inc 0$00.00%
Squarepoint Ops LLC 17,984$14,0000.00%
TWO SIGMA INVESTMENTS, LP 106,341$85,0000.00%
OSAIC HOLDINGS, INC. 29,477$24,0000.00%
View complete list of DIFFUSION PHARMACEUTICALS IN shareholders